Colorectal Cancer clinical trials in New Mexico

6 actively recruiting colorectal cancer trials at 4 sites across New Mexico.

Data from ClinicalTrials.gov · last refreshed 2026-04-20

Phase 3 Recruiting Academic/Other

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study

This phase III trial compares total ablative therapy and usual systemic therapy to usual systemic therapy alone in treating patients with colorectal cancer that has spread to up to 4 body sites (limited metastatic). The usual approach for …

Sponsor: Alliance for Clinical Trials in Oncology

NCT ID: NCT05673148

Sites in New Mexico:

University of New Mexico Cancer Center — Albuquerque, New Mexico

View on ClinicalTrials.gov →

Phase 3 Recruiting Network

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

This study is being done to answer the following questions: Is the chance of rectal cancer responding the same if chemotherapy alone is given before limited surgery compared to chemotherapy and radiation therapy given together before limit…

Sponsor: Canadian Cancer Trials Group

NCT ID: NCT06205485

Sites in New Mexico:

University of New Mexico Cancer Center — Albuquerque, New Mexico

View on ClinicalTrials.gov →

Phase 1, Phase 2 Recruiting Industry

Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab

This Phase 1/2, first-in-human, open-label, multicenter study follows a 3+3 ascending dose escalation design to determine the MTD/RP2D and to characterize the safety, tolerability, PK, and antitumor effects of LNS8801 alone and in combinat…

Sponsor: Linnaeus Therapeutics, Inc.

NCT ID: NCT04130516

Sites in New Mexico:

University of New Mexico Comprehensive Cancer Center — Albuquerque, New Mexico

View on ClinicalTrials.gov →

Phase 1 Recruiting Industry

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

The main purpose of this study is to evaluate the safety and preliminary efficacy of CHS-114 in combination with toripalimab and/or other standard of care (SOC) compound(s) in participants with advanced or metastatic solid tumors.

Sponsor: Coherus Oncology, Inc.

NCT ID: NCT06657144

Sites in New Mexico:

Christus St Vincent Regional Medical Center — Santa Fe, New Mexico

View on ClinicalTrials.gov →

Recruiting Academic/Other

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in th…

Sponsor: Alliance for Clinical Trials in Oncology

NCT ID: NCT05334069

Sites in New Mexico:

Lovelace Medical Center-Saint Joseph Square — Albuquerque, New Mexico
University of New Mexico Cancer Center — Albuquerque, New Mexico
Lovelace Women's Hospital — Albuquerque, New Mexico
Presbyterian Kaseman Hospital — Albuquerque, New Mexico
Memorial Medical Center-Las Cruces — Las Cruces, New Mexico

View on ClinicalTrials.gov →

Recruiting Industry

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinic…

Sponsor: Massive Bio, Inc.

NCT ID: NCT03452774

Sites in New Mexico:

Massive Bio SYNERGY-AI site — Albuquerque, New Mexico

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20